ID   JEG-3/VP16-IL-2
AC   CVCL_6923
DR   Wikidata; Q54898567
CC   Population: Caucasian.
CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).
CC   Transfected with: HGNC; 6001; IL2.
CC   Miscellaneous: Formerly the CCRID database had an entry describing this cell line (3111C0001CCC000073). It was the sole source of information for this entry.
CC   Derived from site: Metastatic; Fetal brain; UBERON=UBERON_0006237.
ST   Source(s): CCRID
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 9,11
ST   D16S539: 13,14
ST   D18S51: 14
ST   D19S433: 13,15
ST   D21S11: 30
ST   D2S1338: 24
ST   D3S1358: 15,16
ST   D5S818: 10,11
ST   D7S820: 10,12
ST   D8S1179: 12
ST   FGA: 21,23,24
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4646; Gestational choriocarcinoma
DI   ORDO; Orphanet_99926; Gestational choriocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_6922 ! JEG-3/VP16
SX   Male
AG   Fetus
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 18
//